134 related articles for article (PubMed ID: 19242403)
21. Minimal interaction between fluoxetine and multiple-dose zolpidem in healthy women.
Allard S; Sainati S; Roth-Schechter B; MacIntyre J
Drug Metab Dispos; 1998 Jul; 26(7):617-22. PubMed ID: 9660843
[TBL] [Abstract][Full Text] [Related]
22. Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone.
Greenblatt DJ; von Moltke LL; Harmatz JS; Fogelman SM; Chen G; Graf JA; Mertzanis P; Byron S; Culm KE; Granda BW; Daily JP; Shader RI
J Clin Pharmacol; 2003 Apr; 43(4):414-22. PubMed ID: 12723462
[TBL] [Abstract][Full Text] [Related]
23. EEG profile of intravenous zolpidem in healthy volunteers.
Patat A; Trocherie S; Thebault JJ; Rosenzweig P; Dubruc C; Bianchetti G; Court LA; Morselli PL
Psychopharmacology (Berl); 1994 Feb; 114(1):138-46. PubMed ID: 7846196
[TBL] [Abstract][Full Text] [Related]
24. The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function.
Wilkinson CJ
J Clin Psychiatry; 1995 Jul; 56(7):309-18. PubMed ID: 7615484
[TBL] [Abstract][Full Text] [Related]
25. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
[TBL] [Abstract][Full Text] [Related]
26. Effects of trazodone on polysomnography, blood concentration and core body temperature in healthy volunteers.
Yamadera H; Suzuki H; Nakamura S; Endo S
Psychiatry Clin Neurosci; 1999 Apr; 53(2):189-91. PubMed ID: 10459685
[TBL] [Abstract][Full Text] [Related]
27. Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults.
Greenblatt DJ; Harmatz JS; Roth T; Singh NN; Moline ML; Harris SC; Kapil RP
Clin Ther; 2013 May; 35(5):604-11. PubMed ID: 23541711
[TBL] [Abstract][Full Text] [Related]
28. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.
Otmani S; Demazières A; Staner C; Jacob N; Nir T; Zisapel N; Staner L
Hum Psychopharmacol; 2008 Dec; 23(8):693-705. PubMed ID: 18763235
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjects.
Greenblatt DJ; Harmatz JS; Singh NN; Steinberg F; Roth T; Harris SC; Kapil RP
Drugs Aging; 2014 Oct; 31(10):731-6. PubMed ID: 25246162
[TBL] [Abstract][Full Text] [Related]
31. Comparative tolerability, pharmacodynamics, and pharmacokinetics of a metabolite of a quinolizinone hypnotic and zolpidem in healthy subjects.
Dingemanse J; Bury M; Hussain Y; van Giersbergen P
Drug Metab Dispos; 2000 Dec; 28(12):1411-6. PubMed ID: 11095577
[TBL] [Abstract][Full Text] [Related]
32. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
Blin O; Micallef J; Audebert C; Legangneux E
J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
[TBL] [Abstract][Full Text] [Related]
33. Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tablets.
Greenblatt DJ; Harmatz JS; Singh NN; Roth T; Harris SC; Kapil RP
J Clin Pharmacol; 2013 Nov; 53(11):1194-8. PubMed ID: 23939537
[TBL] [Abstract][Full Text] [Related]
34. Effects of zolpidem and zopiclone on cognitive and attentional function in young healthy volunteers: an event-related potential study.
Nakajima T; Takazawa S; Hayashida S; Nakagome K; Sasaki T; Kanno O
Psychiatry Clin Neurosci; 2000 Feb; 54(1):37-40. PubMed ID: 15558877
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics, bioavailability, and hemodynamic effects of trazodone after intravenous and oral administration of a single dose to dogs.
Jay AR; Krotscheck U; Parsley E; Benson L; Kravitz A; Mulligan A; Silva J; Mohammed H; Schwark WS
Am J Vet Res; 2013 Nov; 74(11):1450-6. PubMed ID: 24168312
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
37. Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences.
Greenblatt DJ; Wright CE; von Moltke LL; Harmatz JS; Ehrenberg BL; Harrel LM; Corbett K; Counihan M; Tobias S; Shader RI
Clin Pharmacol Ther; 1998 Sep; 64(3):237-47. PubMed ID: 9757147
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem.
Chouinard G; Lefko-Singh K; Teboul E
Cell Mol Neurobiol; 1999 Aug; 19(4):533-52. PubMed ID: 10379424
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications.
Salvà P; Costa J
Clin Pharmacokinet; 1995 Sep; 29(3):142-53. PubMed ID: 8521677
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cytochrome P450 3A by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteers.
Liukas A; Hagelberg NM; Kuusniemi K; Neuvonen PJ; Olkkola KT
J Clin Psychopharmacol; 2011 Jun; 31(3):302-8. PubMed ID: 21508859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
